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lck to other kinases associated with the TCR complex,Tak W. Mak,*³ and Pamela S. Ohashi*
ultimately leading to downstream signaling. However,*Ontario Cancer Institute
TCR transgenic mice expressing mutant CD8 moleculesDepartments of Medical Biophysics
that are unable to associate with lck are still able toand Immunology
undergo thymocyte selection (Chan et al., 1993), sug-Toronto, Ontario M5G 2M9
gesting that CD8±lck interactions are not essential forCanada
T cell maturation. Similar results were obtained using²R. W. Johnson Pharmaceutical
mutant CD4 molecules (Killeen and Littman, 1993). Addi-Research Institute
tional experiments using TCR transgenic mice lacking3535 General Atomics Ct.
the CD8a cytoplasmic domain have shown a defect inSan Diego, California 92121
MHC class I±restricted positive selection, suggesting³Amgen Institute
that an intracellular portionof CD8a is involved in thymo-620 University Ave.
cyte development (Fung-Leung et al., 1993). RecentToronto, Ontario M5G 2C1
work has also implicated the CD8b chain in signalingCanada
during T cell maturation (Crooks and Littman, 1994;
Fung-Leung et al., 1994; Itano et al., 1994a; Nakayama
et al., 1994). Therefore, the exact function of CD8 duringSummary
thymocyte selection remains unresolved. In addition to
a potential role in signaling, experiments have demon-T cell receptor (TCR) transgenic thymocytes specific
strated that coreceptors contribute to thymocyte±for the LCMV gp peptide are normally positively se-
stromal cell avidity (Knobloch et al., 1992; Lee et al.,lected to the CD8 lineage. Transgenic thymocyte de-
1992; Robey et al., 1992; Sherman et al., 1992), whichvelopment was substantially reduced in the absence
may in turn affect T cell development. The importanceof these CD8 coreceptors. However, efficient positive
of coreceptors during thymocyte maturation was furtherselection was restored when TCR transgenic CD82/2
illustrated using transgenic mice expressing mutantfetal thymic lobes were cultured with a peptide variant
MHC class I molecules that did not associate with CD8of thewild-type ligand.These mature thymocytes were
(Aldrich et al., 1991; Ingold et al., 1991; Killeen et al.,functional, as shown by their ability to respond against
1992). Positive and negative selection was disrupted instrong peptide agonists. Additional experiments dem-
these experiments, indicating that coreceptors are a key
onstrated that transgenic positive selection was pep-
component of thymocyte development.
tide-specific. These results prove that CD8 does not
Another significant aspect of thymocyte ontogenypossess essential signaling properties that are neces-
deals with coreceptor down-regulation (for reviews, seesary for T cell development. In addition, the unilateral
Chan et al., 1994; Davis and Littman, 1994; Robey, 1994;
commitment of transgenic thymocytes to mature
Fowlkes and Schweighoffer, 1995; von Boehmer, 1996).
CD42TCRhi T cells expressing intracellular perforin
An instructive model proposes that TCR MHC restriction
suggests that there must be some instructive compo-
determines lineage commitment. T cells expressing
nent to CD4 down-regulation and lineage commitment MHC class I± or class II±restricted TCRs down-regulate
during thymocyte selection. CD4 or CD8, respectively. Alternatively, coreceptor
down-regulation could be an arbitrary event. According
Introduction to a stochastic model, initial TCR stimulation leads to
random coreceptor down-regulation. Continued matu-
T cell maturation actively selects for functional thy- ration is dependent on a properly matched MHC-
mocytes that can interact with self±major histocom- restricted TCR and coreceptor. Early experiments using
patibility complex (MHC) while tolerizing potentially TCR transgenic mice showed a strong correlation be-
autoreactive T cells. Concurrent with this selection pro- tween MHC-restriction and lineage commitment (Kisie-
cess, CD41CD81 double-positive thymocytes differenti- low et al., 1988; Sha et al., 1988; Teh et al., 1988; Berg
ate into CD41 or CD81 single-positive T cells. This lin- et al., 1989; Kaye et al., 1989; Scott et al., 1989), arguing
eage commitment strongly correlates with helper or in favour of an instructive model for thymocyte develop-
cytotoxic T cell function, respectively. The CD4 and CD8 ment. These findings were further supported by studies
coreceptors have been implicated in all of these stages using mice transgenic for both TCRs and coreceptors.
of thymocyte development, although the extent of their For example, HY-specific TCR1CD8tg transgenic mice
participation remains unclear. The protein tyrosine ki- did not rescue CD41 thymocytes as would be expected
nase p56lck, which is thought to be involved in early according to a stochastic model (Borgulya et al., 1991;
T cell receptor (TCR)±induced intracellular signaling and Robey et al., 1991). However, additional experiments
thymocyte development (Molina et al., 1992; Levin et using transgenic mice expressing different TCRs were
al., 1993), has been shown to bind noncovalently to a able to inefficiently rescue mismatched coreceptors,
common CXCP motif found in the cytoplasmic domain suggesting that the stochastic model may in fact be
of both of these coreceptors (Shaw et al., 1990; Turner valid (Davis et al., 1993; Corbella et al., 1994; Itano et
al., 1994b). Further evidence was found by examininget al., 1990). Models have proposed that coengagement
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thymocyte development in MHC deficient mice. A transi-
tional stage of CD41CD8loTCRint thymocytes were found
in mice lacking class II, suggesting that lineage commit-
ment was a random event (Chan et al., 1993). Likewise,
a CD4loCD81TCRint thymocyte population was found in
class I±deficient mice (van Meerwijk and Germain, 1993).
Although mistakes have been found in lineage commit-
ment, the significance of these cell populations remains
unclear.
To understand more fully the role of coreceptors
during thymocyte ontogeny, we studied MHC class
I±restricted transgenic T cell maturation in the absence
of CD8. Previous work has demonstrated that thymo-
cyte±stromal cell avidity affects positive and negative
selection (Ashton-Rickardt et al., 1994; Sebzda et al.,
1994). Therefore, we wanted to determine whether pep-
tide variants could contribute significantly to thymocyte
avidity in order to compensate for absent coreceptors
during T cell ontogeny. The system used in these experi-
ments allowed us to analyze thymocyte development in
a coreceptor-independent manner, and thus provided
us with a unique ability to address unresolved problems
concerning lineage commitment and the role of core-
ceptors during thymocyte maturation.
Results
T Cell Maturation Induced in a
Coreceptor-Independent Manner
Figure 1. TCR Transgenic Thymocyte Development Can Occur inThe role of the CD8 coreceptor during positive selection
the Absence of CD8 Coreceptors
was examined using TCR transgenic mice that ex-
(A) Positive selection of TCR transgenic thymocytes is greatly re-
pressed receptors (Va2/Vb8.1) specific for the lympho- duced in CD8-deficient mice. Thymocytes from TCR CD81/1 and
cytic choriomeningitis virus (LCMV) peptide (KAVYN- TCR CD82/2 mice were triple stained with antibodies specific for
FATC) presented by H-2Db. Thymocyte maturation in CD8, CD4, and Va2. Total thymocytes are shown for dot plots and
histograms.this mouse model was characterized by a skewing to
(B) The peptide A4Y efficiently induces transgenic positive selectionthe CD81 lineage and high surface expression of the
in TCR CD82/2 FTOC. TCR CD82/2 thymic lobes were cultured withtransgenic TCR (Figure 1A). Peripheral CD81 T cells also
AV (control H-2Db±restricted adenovirus peptide) or A4Y and then
expressed the transgenic TCR (Table 1). In contrast, stained with antibodies specific for CD4 and Va2. TCR CD81/1 lobes
very few TCRhi thymocytes were detected in TCR CD82/2 were used as a positive control. This experiment was repeated eight
mice, although a few CD42CD82 or CD41CD82 TCRhi T times, with similar results.
cells were detected in the periphery. Coreceptors have
been shown to contribute to thymocyte avidity and
affect T cell development (Lee et al., 1992; Robey et controls were stained with the maturity markers, heat-
stable antigen (HSA) and peanut agglutinin (PNA).al., 1992; Sherman et al., 1992). Therefore, we wanted
to determine whether peptide variants could increase CD42Va2hi thymocytes from A4Y-treated or positive
control FTOCs expressed low levels of HSA and PNA,thymocyte avidity sufficiently to overcome the require-
ment for CD8 molecules during positive selection. characteristic of mature thymocytes (Figure 2). In con-
trast, CD41Va2int cells from these cultures had highFetal thymic lobes from TCR CD82/2 mice were cultured
with a control, H-2Db±restricted adenovirus peptide, AV surface expression of HSA and PNA, similar to that found
on wild-type CD41CD81 double-positive thymocytes.(SGPSNTPPEI). Compared to thymocyte maturation in
TCR CD81 fetal thymic organ cultures (FTOCs), these CD42Va2int thymocytes expressed intermediate levels
of maturity markers relative toCD41Va2int and CD42Va2hiCD8-deficient lobes had a substantially reduced
CD42Va2hi transgenic cell population (Figure 1B). How- cells, suggesting that transgenic thymocytes pro-
gressed from a CD41 to a CD42 stage prior to becomingever, TCRhi transgenic thymocyteswere recovered when
TCR CD82/2 fetal thymic lobes were cultured in the pres- mature, CD42Va2hi cells. Together, these results con-
firmed that CD42Va2hi thymocytes were a mature T cellence of the peptide variant, A4Y (KAVANFATM), which
has previously been shown to positively select TCR population that had undergone positive selection.
The CD42Va2hi cell numbers summarized in Table 2CD81 thymocytes (Sebzda et al., 1996). These results
indicate that CD8 coreceptors are an important, but not demonstrate the relative importance of CD8 during posi-
tive selection. Thymic lobes lacking this coreceptor hadmandatory, component of T cell development.
To ensure that these CD42Va2hi thymocytes had un- a reduced ability to produce mature thymocytes ex-
pressing the transgenic TCR. Addition of A4Y compen-dergone positive selection, T cells from TCR CD82/2
organ cultures treated with A4Y or from TCR CD81 sated for the absent coreceptor and provided adequate
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Table 1. Transgenic Splenocyte Numbers from TCR CD81 and TCR CD82/2 Littermates
CD81Va2hi CD41Va2hi CD82CD42Va2hi
TCR CD81 1.9 6 0.3 3 107 1.2 6 0.2 3 106 1.2 6 0.3 3 106 n 5 4
TCR CD82/2 0 5.6 6 0.5 3 106 4.1 6 0.4 3 106 n 5 4
Data are shown 6 SD.
stimulation to positively select CD42Va2hi thymocytes. peptide concentrations (1024±1025 M), A3V induced pro-
liferation to the same degree as p33. At lower concentra-The efficiency of A4Y-induced positive selection was
examined by testing this peptide in TCR CD82/2 FTOCs tions (1027±10211 M), A3V and A4Y induced almost identi-
cal amounts of proliferation.at various concentrations. A titration profile of A4Y (Fig-
ure 3) showed that positive selection occurred over a To determine the relative importance of CD8 in pep-
tide-specific interactions, TCR transgenic splenocytesbroad concentration range, extending from 1025 to 1029
M. Together, these results demonstrated that A4Y effi- were stimulated with peptide-coated APCs in the pres-
ence of anti-CD8 monoclonal antibodies (Figure 4B).ciently induced positive selection of transgenic thymo-
cytes in a coreceptor-independent manner. High antibody concentrations inhibited T cell prolifera-
tion in response to all of the peptides, although not to
the same extent. A4Y did not induce T cell proliferation.Peptide-Specific Positive Selection
of TCR CD82/2 Thymocytes In contrast, reduced proliferation was seen with p33 and
A3V. Notably, A3V did not seem to be as affected by theAlthough A4Y positively selected TCR CD82/2 thymo-
cytes, it was possible that this peptide was simply com- blocking antibody as p33. Similar proliferation patterns
were observed with lower concentrations of anti-CD8.pensating for lost avidity due to a lack of coreceptors,
and not providing a unique TCR ligand that could pro- In general, anti-CD8 antibody inhibited transgenic T cell
proliferation in response to all of the peptides tested;mote positive selection. For this reason, we searched
for peptide variants that were similar in nature to A4Y however, A3V and p33 were much more efficient at stim-
ulating CD8-independent proliferation than A4Y. Theseto determine whether these peptides could efficiently
induce positive selection. Initially we tested potential assays indicated that TCR±A3V/MHC interactions were
stronger and less CD8-dependent than those involvingpeptides to ensure that they bound to H-2Db molecules.
Using TAP-2 (transporter associated with antigen pro- A4Y. Hence, these results suggested that A3V was at
least as potent an agonist peptide as A4Y.cessing type 2)±deficient RMA-S cells, type 2, we were
able to demonstrate that each of the relevant peptides To determine whether A3V could induce positive se-
lection in the absence of CD8, this peptide was testedrescued H-2Db surface expression (Figure 4A).
Since these peptides could bind to H-2Db, we further in TCR CD82/2 FTOCs. As shown in Figure 5A, TCR
CD82/2 thymocytes cultured with high concentrationstested these ligands for their ability to stimulate
transgenic T cells. Previous experiments revealed that of p33 or A3V (1026 M) underwent clonal deletion. This
was characterized by a dramatic reduction in the per-A4Y, an alanine-variant of the wild-type peptide, was an
agonist with no detectable antagonist properties (Seb- centage of CD42Va2hi and CD41 Va2int thymocytes and
a decrease in absolute cell numbers. Previous experi-zda et al., 1996). As shown in Figure 4B, antigen-pres-
enting cells (APCs) pulsed with various concentrations ments have demonstrated that clonal deletion occurs
during high-avidity TCR±peptide/MHC interactions.of this modified peptide induced TCR CD81 splenocyte
proliferation. Similar concentrations of the strong pep- Therefore, these current results suggest that the TCR±
A3V/H-2Db interaction is strong enough to provide suffi-tide agonist, p33 (KAVYNFATM), resulted in increased
proliferation. However, transgenic splenocytes stimu- cient avidity for clonal deletion to occur at high peptide
concentrations.lated with the peptide variant, A3V (KAAYNFATM), pro-
liferated at rates common to both peptides. At high If A4Y-induced positive selection was due simply to
Figure 2. Thymocytes Expressing High Levels of the Transgenic Receptor Are Mature
Positive control TCR CD81/1 or TCR CD82/2 thymic lobes cultured with A4Y were stained with antibodies specific for CD4, Va2, and HSA or
PNA. HSA and PNA profiles are shown from gated CD41Va2int, CD42Va2int, or CD42Va2hi cells. Similar results were obtained when these
experiments were repeated three times.
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Table 2. Transgenic Thymocyte Numbers from FTOCs Treated with or without A4Y
Total Thymocyte Number CD42Va2hi
TCR CD81 7.4 6 0.5 3 105 1.9 6 0.1 3 105 n 5 5
TCR CD82/2 no peptide 7.3 6 1.7 3 105 1.0 6 0.2 3 105 n 5 6
TCR CD82/2 A4Y (1026 M) 10 6 1.7 3 105 2.4 6 0.4 3 105 n 5 5
Data are shown 6 SD.
the peptide increasing thymocyte±stromal cell avidity to APCs coated with p33 (Figure 6A). Positively selected
TCRhi CD82/2 thymocytes did not respond as vigorouslycompensate for absent coreceptors, then nondeleting
concentrations of A3V should have had a similar effect. as the TCR CD81 controls, consistent with the previous
anti-CD8 mAb proliferation experiments. Neither Va2hiInstead, as shown in Figure 5B, the highest concentra-
tion of A3V (1028 M) that did not induce detectable CD81 nor Va2hi CD82/2 thymocytes proliferated when
cultured with a control H-2Db±restricted adenovirus pep-amounts of clonal deletion, had no effect on T cell devel-
opment. Low concentrations of A3V neither positively tide, AV, demonstrating that proliferation was peptide
specific. As expected, APCs coated with A4Y inducednor negatively selected transgenic thymocytes. This is
in marked contrast to similar concentrations of A4Y, moderate levels of TCRhi CD81 proliferation. In contrast,
TCR CD82/2 thymocytes that were positively selectedwhich resulted in positive selection. Even lower concen-
trations of A3V (1029±10212 M) also had no effect on with this peptide did not respond against A4Y. To deter-
mine whether TCR proliferative responses were depen-thymocyte selection (data not shown), demonstrating
that potential TCR transgenic positive selection was not dent on CD8, proliferation assays were done using
splenocytes from TCR CD82/2 mice. Mature TCR CD82/2being masked by clonal deletion. For this reason, we
suggest that TCR CD82/2 thymocyte maturation is pep- T cells could proliferate in response to p33 but not A4Y
(Figure 6B), indicating that A4Y-induced proliferationtide specific.
was CD8 dependent. Therefore, a lack of TCR CD82/2
thymocyte proliferation was expected when stimulatedSpecific Proliferative Response of Positively
Selected TCR CD82/2 Thymocytes with A4Y. As a result, we could not distinguish between
inherent unresponsiveness due to a lack of coreceptorsProliferation assays were conducted to determine
whether TCR CD82/2 thymocytes selected in the pres- and tolerance induced by the selecting ligand. However,
we conclude that A4Y promoted TCR CD82/2 thymocyteence of A4Y were functional. Mature CD42Va2hi T cells
from TCR CD82/2 thymic lobes cultured with A4Y and maturation of functional T cells.
TCR CD81 controls both proliferated in response to
Mature TCR CD82/2 Thymocytes Were
Committed to the Cytotoxic Lineage
Having established that TCR CD82/2 thymocytes posi-
tively selected in the presence of A4Y were functional,
we wanted to determine whether these transgenic cells
were committed to the cytotoxic lineage. Previous in
vivo experiments have demonstrated that single-posi-
tive mature CD81 cytotoxic thymocytes characteristi-
cally expressed high levels of perforin, in contrast to
the low levels expressed by mature CD41 helper cells
(Vandekerckhove et al., 1994). Therefore, we examined
mature transgenic thymocytes for the presence of intra-
cellular perforin. To ensure that only positively selected
transgenic thymocytes were being analyzed, thymic T
cells were initially sorted for high surface expression
of the transgenic TCR. These lymphocytes were then
stained for intracellular perforin. As shown in Figure 7,
the majority of CD42Va2hi T cells from fetal thymic lobes
cultured in the presence of A4Y positively stained for
perforin. Likewise, Va2hi thymocytes from an adult posi-
tive control TCR RAG2/2 thymus expressed similar high
levels of intracellular perforin. Mature thymocytes from
a CD82/2 thymus, which lack a significant cytotoxic T
cell population (Fung-Leung et al., 1991), were used as
Figure 3. The Peptide A4Y Induces Positive Selection of TCR
a negative control. These thymocytesclearly lackedhighCD82/2 Thymocytes over a Wide Concentration Range
levels of perforin. Since positively selected CD42Va2hi
TCR CD82/2 thymic lobes were cultured with different concentra-
thymocytes expressed perforin, this experiment demon-tions of A4Y and analyzed with antibodies specific for CD4 and Va2.
strated these thymocytes were committed to the cyto-CD42Va2hi cell numbers are included for this experiment. These
data are representative of three experiments. toxic lineage in the absence of CD8.
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Figure 4. The H-2Db±Binding Peptide A3V
Can Activate Mature T cells and Induce Inter-
mediate Levels of Proliferation Relative to
p33 and A4Y
(A) Peptides were tested for their ability to
bind and rescue H-2Db surface expression
on RMA-S cells relative to a control peptide,
LCMV nucleoprotein 118±127 (H-2Dd re-
stricted). RMA-S cells were cultured with se-
rial dilutions of p33 (squares), A3V (circles),
A4Y (triangles), or AV (diamonds).
(B) The proliferative response of mature
spleen cells from TCR transgenic mice was
measured when stimulated with H-2b spleen
cells pulsed with various concentrations of
p33 (squares), A3V (circles), or A4Y (triangles)
in the presence or absence of anti-CD8
blocking antibody. Background proliferation
was less than 100 cpm. This experiment was
repeated four times, with similar results.
Discussion al., 1992; Fung-Leung et al., 1993; Penninger et al., 1995)
and the development of helper or cytotoxic effector
functions (Fung-Leung et al., 1991; Rahemtulla et al.,Various experiments have demonstrated that the CD4
and CD8 coreceptors play an important role during T 1991; Locksley et al., 1993; Rahemtulla et al., 1994; Dal-
loul et al., 1996) can occur independently of coreceptors.cell maturation. Although the coreceptors have an im-
mediate effect on many aspects of thymocyte develop- For this reason, we wanted to determine whether MHC
class I±restricted transgenic thymocytes could be posi-ment, the possibility remains that these molecules are
not absolutely required for lineage commitment or thy- tively selected in a peptide-specific manner without CD8
coreceptors. TCR transgenic thymocytes specific formocyte selection. Indeed, previous reports have shown
that processes such as negative selection (Wallace et LCMV in the context of H-2Db were positively selected
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Figure 6. TCR CD82/2 Thymocytes Selected in the Presence of A4Y
Proliferate in Response to Strong Agonists
(A) Positively selected CD42Va2hi thymocytes from TCR CD82/2 thy-
mic lobes cultured with A4Y (open bars) or CD81Va2hi cells from
TCR CD81/1 thymic lobes cultured in media alone (closed bars)
were stimulated with peptide-coatedAPC. Background proliferation
was 200 cpm. These results are representative of four experiments.
(B) Mature transgenic T cells from TCR CD82/2 mice cannot prolifer-
ate in response to A4Y. Spleen cells from TCR CD82/2 mice were
Figure 5. The Peptide A3V Can Induce Clonal Deletion but Not Posi- stimulated with APCs prepulsed with p33 (squares) or A4Y (trian-
tive Selection of TCR CD82/2 Thymocytes gles). Background proliferation was 800 cpm.
(A) TCR CD82/2 thymocytes were clonally deleted using high con-
centrations of A3V or p33. Thymocytes from TCR CD82/2 fetal lobes
A3V induced TCR CD82/2 clonal deletion, further dem-cultured with or without p33 or A3V were stained with antibodies
specific for CD4 and Va2. CD42Va2hi thymocyte numbers are in- onstrating that CD8 is not required for negative selec-
cluded for this experiment. Similar results were obtained when this tion. Therefore, these experiments demonstrate that
experiment was repeated three times. CD8 coreceptors are not absolutely required to govern
(B) Positive selection of transgenic thymocytes is detected in the
peptide-specific MHC class I±restricted thymocyte se-presence of A4Y but not A3V. TCR CD82/2 thymocytes cultured in
lection.the presence of A3V or A4Y were stained with CD4 and Va2 specific
One of the repercussions of these findings concernsantibodies. Again, CD42Va2hi thymocyte numbers are shown. Data
are representative of five experiments. early intracellular signaling following TCR engagement
during thymocyte development. The cytoplasmic pro-
tein tyrosine kinase p56lck has been implicated in the
initiation of kinase signaling pathways (Weiss and Litt-to the CD8 lineage. In the absence of this coreceptor,
mature transgenic thymocyte numbers were greatly di- man, 1994). A member of the Src family of tyrosine ki-
nases, lck noncovalently associates with the CD8aminished, emphasizing the role of CD8 during positive
selection. However, when TCR CD82/2 thymic lobes chain. Models predicted that coengagement of the TCR
and CD8 by an MHC molecule would result in the recruit-were cultured with the peptide A4Y, efficient positive
selection of transgenic thymocytes was restored. High ment of lck to the TCR complex, ultimately leading to the
phosphorylation and activation of associated tyrosineexpression of intracellular perforin confirmed that these
cells were committed to the cytotoxic lineage. In addi- kinases and downstream signaling. However, the pres-
ent work supports previous findings which have sug-tion, these positively selected TCR CD82/2 thymocytes
were able to respond against the strong agonist p33, gested that coreceptor±lck association is not essential
for T cell development. Although lck has an importantconfirming that these cells were functional. Fetal thymic
organ cultures containing high concentrations of p33 or role during thymocyte ontogeny, it does not have to be
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CD82/2 positive selection was in fact a peptide-specific
process that occurred independently of coreceptors.
We believe that A4Ywas not simply ªhelpingº a variety of
naturally occurring CD8-dependent positively selecting
peptides but was instead providing distinct ligands
which promoted transgenic thymocyte maturation.
The positively selecting peptide A4Y was able to inter-
act with the transgenic TCR in a manner that A3V was
not able to duplicate. One interpretation of these results
incorporates an efficacy model of thymocyte selection
(Mannie, 1991). A peptide that is able to generate a TCR-
mediated biological function is described as having
efficacy. According to this model, positively selecting
ligands lack efficacy, whereas negatively selecting pep-
tides are capable of stimulating T cell activity. Antago-
nist peptides, which by definition lack efficacy, have
been shown to induce positive selection (Hogquist et
al., 1994; Jameson et al., 1994; Hogquist et al., 1995).
The current study suggested that the peptide A4Y did
not have efficacy in the absence of CD8, yet was able
to mediate positive selection. A3V was able to stimulate
T cell proliferation in a relatively CD8-independent man-
ner and induced clonal deletion at high concentrations.
Although these data are compatible with an efficacyFigure 7. Positively Selected TCR CD82/2 Thymocytes Express Per-
model, previous studies conflict with this interpretationforin
of thymocyte development. Using the LCMV-specificCD42Va2hi thymocytes from TCR CD82/2 thymic lobes cultured with
A4Y or CD81Va2hi thymocytes from TCR RAG2/2 and CD41Va2hi TCR b2m2/2 mouse model, we have demonstrated that
thymocytes from CD82/2 mice were stained with perforin-specific A4Y can positively select thymocytes at concentrations
mAb. This experiment was repeated three times. sufficient to induce TCR b2m1 or TCR b2m2/2 T cell
activity (Sebzda et al., 1996; E. S., unpublished data).
Therefore, there is no direct correlation between the
recruited via CD8 to participate in TCR-induced tyrosine ability of A4Y to induce positive selection and its ability
phosphorylation pathways. Indeed, the effective selec- to stimulate T cell activity. These results are further sup-
tion of transgenic thymocytes in the absence of CD8 ported by experiments showing that positively selecting
demonstrated that this coreceptor does not contain in- ligands do not have to act as antagonists (Ignatowicz et
trinsic properties that are crucial for T cell maturation. al., 1996). In addition, severalgroups have demonstrated
Furthermore, since the CD8a chain is required for CD8b that antagonist peptides can block thymocyte selection
surface expression, this study demonstrates that thymo- (Spain et al., 1994; Williams et al., 1996) or promote
cyte development can occur in the absence of both the clonal deletion (Page et al., 1994). For these reasons, we
CD8 a and b chains. Therefore, CD8 does not play an do not favor an efficacy model of thymocyte selection.
obligatory role in intracellular signaling or lineage com- An alternative interpretation of these experiments is
mitment during thymocyte development. that, unlike A3V, A4Y was capable of inducing a confor-
If the CD8 coreceptor is not strictly required for intra- mational change within the transgenic TCR that was
cellular signaling during thymocyte development, then optimal for positive selection. It has been postulated
perhaps its main function is to stabilize TCR±MHC class that this conformational change stimulates incomplete
I interactions. Efficient TCR transgenic positive selection TCR-mediated signaling, resulting in positive selection
required CD8 binding in addition to endogenous pep- (Janeway, 1994, 1995). However, experiments have
tide±TCR interactions, suggesting that natural endoge- demonstrated that A4Y can activate mature TCR
nous ligands had too low an affinity or were present at transgenic T cells, suggesting that this ligand induces
too low a concentration for transgenic thymocytes to a TCR conformation capable of providing complete sig-
survive without additional avidity provided by corecep- nals. Since high concentrations of A4Y can promote
tors. Theoretically, A4Y could have induced transgenic TCR transgenic positive selection (Sebzda et al., 1996),
positive selection by increasing the number of TCR± this argues against a conformational model that relies
peptide/MHC interactions and therefore restoring thy- on incomplete TCR signaling for thymocyte develop-
mocyte avidity. However, experiments using A3V sug- ment. At the same time, we do not rule out the possibility
gested that this was not the case. This peptide variant that A4Y has some unique features distinct from its
had sufficient affinity to induce clonal deletion, and yet properties as a weak agonist.
lower concentrations of A3V did not induce efficient Instead, we suggest that TCR-peptide/MHC affinity
positive selection. If peptide-induced positive selection and thymocyte±stromal cell avidity are at least two com-
was simply a means of compensating for lost avidity ponents that regulate T cell development. Recent stud-
associated with the CD8 coreceptor, then low concen- ies demonstrated that specific transgenic TCRs have a
trations of A3V should have promoted TCR CD82/2 mat- low affinity for positively selecting ligands (Alam et al.,
uration. Since A3V could not produce a similar pheno- 1996). Therefore, it is possible that efficient T cell matu-
ration could not be detected using A3V because of atype as A4Y, these results argue that efficient TCR
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cultured with A4Y-coated APCs (Figure 4B). There was
little variation in terms of absolute proliferation over an
extended range of A4Y peptide concentrations. To-
gether, these results suggest that both TCR-peptide/
MHC affinity and avidity regulate T cell development,
consistent with an affinity/avidity model of thymocyte
selection.
The ability to positively select transgenic thymocytes
in a coreceptor-independent manner has direct implica-
tions for lineage commitment. An instructive model pro-
poses that TCR engagement initiates distinct intracellu-
lar signals that direct thymocytes to the appropriate
lineage according to the restricting element. Thymo-
cytes bearing MHC class I±specific TCRs down-regulate
CD4 expression while MHC class II±specific T cells ter-
minate CD8 expression. An alternative model postulates
that the initial signal through the TCR prompts thymo-
Figure 8. Potential Relationship between Thymocyte Stimulation
cytes to down-regulate randomly one of the corecep-and Increasing Concentrations of Specific Peptides, in an Affinity/
tors. According to this stochastic model, properlyAvidity Model of Thymocyte Selection
matched TCRs and coreceptors allows thymocytes toPositive and negative selection thresholds are defined by the accu-
survive. If this model was correct and thymocytes ran-mulation of TCR-mediated signaling, which in turn is primarily gov-
erned by thymocyte±stromal cell avidity. The rate at which thymo- domly down-regulate coreceptors, then we should have
cyte signaling increases is subject to the affinity of the specific been able to detect a substantial number of CD41Va2hi
peptide. High-affinity ligands promote high rates of thymocyte stim- T cells. Instead, we were only able to observe a mature
ulation at low peptide concentrations. This results in a narrow range
CD42Va2hi thymocyte population, suggesting that CD4of peptide concentrations during which positive selection can occur.
coreceptors were actively being down-regulated in anIn contrast, low-affinity peptides can induce positive selection over
instructive manner. A recent study using MHC classa larger range of peptide concentrations because of the reduced
rate of thymocyte signaling generated by this ligand. II±restricted transgenic T cells has shown that under
certain circumstances, mature cells may be selected
from a CD42CD82 population without passing through
relatively high-affinity interaction with the transgenic a double-positive stage (Liu et al., 1996). However, using
TCR. In contrast, A4Y had sufficiently low affinity to this LCMV-specific TCR transgenic mouse model, it is
promote positive selection. Current affinity/avidity mod- possible to follow thymocyte maturation through the up-
els postulate that positive and negative selection events regulation of the transgenic TCR (Ohashi et al., 1990)
have defined avidity thresholds and that higher-avidity The lack of a consistent, substantial CD42 population
conditions are required for clonal deletion than positive continuously increasing its transgenic TCRs versus the
selection (Sprent et al., 1988). The accumulation of sig- presence of such a population expressing CD4 suggests
nals within a certain time frame, which is primarily gov- that in this system, thymocytes proceeded through a
erned by thymocyte avidity, define these thresholds. CD41 stage prior to maturation (Figure 1B). These find-
High concentrations of A3V or p33 contributed enough ings correlate with experiments following thymocyte
avidity to induce negative selection. At low peptide con- maturity markers. Thymocytes stained with HSA and
centrations, this threshold was not met, resulting in an PNA indicated that CD42Va2int thymocytes were more
absence of clonal deletion. Previous studies have shown mature than CD41Va2int cells, suggesting that T cells
that p33 induced positive selection at lower peptide down-regulated CD4 as they progressed towards a
concentrations and over a much narrower range than CD42Va2hi stage (Figure 2). At the same time, we cannot
A4Y (Ashton-Rickardt et al., 1994; Sebzda et al., 1994, conclusively rule out the possibility that at least some
1996), consistent with theview that the rate of transgenic thymocytes bypassed a CD41 stage during T cell matu-
thymocyte stimulation is subject to the affinity of specific ration. For those cells that didexpress CD4, it is possible
peptides (Figure 8). Since A3V had a relatively high affin- that TCR transgenic thymocytes either directly signaled
ity, as demonstrated in anti-CD8 proliferation assays, CD4 termination through MHC class I±restricted TCRs
this ligand was expected to promote positive selection or, alternatively, down-regulated these coreceptors as
over a limited span of peptide concentrations. It is likely a result of CD4 not being able toparticipate during linage
that this potential window for positive selection was commitment. These results support recent studies that
too small for detection in FTOC, possibly because of have proposed an instructive mechanism to CD4 down-
background levels of thymocyte maturation induced by regulation (Suzuki et al., 1995; Lucas et al., 1996). Since
endogenous ligands. This contrasts with A4Y-induced this instructive mechanism did not require coengage-
positive selection which was easily observed over a ment of CD8 with the TCR, these current findings sug-
broad range of peptide concentrations. This low-affinity gest that MHC class I± restricted T cells down-regulate
ligand did not change thymocyte stimulation as dramati- CD4 expression in accordance with a coreceptor-inde-
cally as A3V and thus was able to provide a positively pendent instructive model.
selecting environment over a larger range of peptide These experiments demonstrate that positive and
concentrations. This interpretation is supported by the negative selection can occur in the absence of CD8,
raising into question the exact role of this coreceptorproliferative response of TCR transgenic spleen cells
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Flow Cytometryduring T cell development. Clearly CD8 is important dur-
All flow cytometric analysis was performed on a FACScan instru-ing positive selection since mature transgenic thymo-
ment (Becton Dickinson). Samples were gated for live cells basedcyte numbers are greatly reduced in the absence of this
on forward and side scatter parameters (10,000 events/sample) and
coreceptor. However, these studies have shown that it analyzed using Lysis II software (Becton Dickinson).
is possible to reestablish a substantial transgenic thy-
mocyte population by culturing fetal lobes with a posi-
Peptides
tivelyselecting peptide, indicating that CD8 is not essen- The peptides p33 (KAVYNFATM), A3V (KAAYNFATM), A4Y (KAVAN-
tial for thymocyte development or lineage commitment. FATM), and adenovirus peptide AV (SGPSNTPPEI) were synthe-
sized, purified, and characterized at the Amgen Institute as pre-Instead, this coreceptor functions as an adaptor mole-
viously described (Sebzda et al., 1996).cule, providing a means for maturing thymocytes to ad-
just to their thymic environment. CD8 molecules may
Peptide-Binding Assayhelp stabilize low-affinity TCR±endogenous peptide/
In peptide-pulsing experiments, 106 RMA-S cells, which were pre-MHC interactions, providing a suitable threshold for
viously cultured overnight at 298C in RPMI plus 10% FCS, were``natural'' thymocyte selection. In the absence of these
incubated with various concentrations of peptide at 298C for 30 min.
coreceptors, thymocyte selection is limited to a small These cells were then transferred to a 378C incubator for 3 hr, after
subset of ligands capable of efficient TCR stimulation. which time the cells were washed and stained with anti-H-2Db mAb
Therefore, CD8 coreceptors expand the TCR repertoire from tissue culture supernatant (B22.249) (Hammerling et al., 1979;
Allen et al., 1986) and then FITC-conjugated rat anti-mouse immuno-by extending the potential body of positively selecting
globulin (Sigma Chemical). RMA-S cells were incubated with LCMVligands to include peptides with transient TCR interac-
nucleoprotein 118±127 (H-2d restricted) (von Herrath et al., 1994) totions. The CD8 coreceptor also expands the potential
determine background H-2Db expression.
antigen repertoire, allowing T cells to respond against
low-affinity peptides. Although CD8 molecules are not
Proliferation Assaysstrictly required for transgenic T cell maturation or differ-
TCR transgenic spleen cells (105/well), cultured previously with or
entiation, the coreceptors enhance the efficiency of without various dilutions of anti-CD8 mAb (YTS 169.4) for 1 hr at
these processes. 378C, were incubated in triplicate in 96-well flat-bottom plates with
2 3 104/well irradiated C57B1/6J (H-2b) splenocytes that had been
Experimental Procedures prepulsed with various concentrations of peptide for 3 hr at 378C.
After 48 hr of cocultivation, the cells were pulsed with 1 mCi of
Mice [3H]thymidine (Amersham, Arlington Heights, IL) for 16 hr. Cells were
TCR-transgenic mice were previously generated using a and b harvested and counted on a direct b counter (Matrix96, Canberra
chains isolated from CTL clone P14, which recognized the LCMV Packard Canada, Mississauga, Ontario, Canada).
glycoprotein (peptide p33±41) presented by H-2Db. This line was
backcrossed with H-2b CD82/2 mice to obtain TCR CD82/2 (H-2b)
FTOC Proliferation Assayanimals. Progeny were typed for transgenic TCR and homozygous
Cultured thymic lobes were teased apart and cultured with 1 mlCD8 disruption by staining peripheral blood with mAbs at 48C in
of anti-HSA (J11d) and 400 ml of Low-Tox-M rabbit complementphosphate-buffered saline (PBS) containing 2% NaN3, and 20 mM (Cedarlane Laboratories, Hornby, Ontario, Canada) for 45 min atEDTA. TCR-transgenic cells were detected with rat anti-mouse
378C. Irradiated spleen cells from a C57B1/6Jmouse were prepulsedVb8.1 (KJ16) mAb followed by fluorescein isothiocyanate (FITC)±
with 1028 M AV, A4Y, or p33 for 3 hr at 378C; washed; and distributedconjugated goat anti-rat Mab (Tago, Burlingame, CA). CD82/2 mice
in triplicate on a flat-bottom 96-well plate at a concentration of 105were screened using rat anti-mouse CD8 (YTS 169.4) mAb followed
cells/well. Mature thymocytes (3 3 104/well) resuspended in IMDM,by FITC-conjugated goat anti-rat mAb. After the second antibody
10% FCS, penicillin, streptomycin, and 5 3 1025 M 2-mercaptoetha-incubation period, red blood cells were lysed using 13 FACS lysing
nol were then added to these wells. The cells were cultured at 378Csolution (Becton Dickinson, Mountain View, CA). TCR RAG2/2 (H-2b)
for 72 hr, pulsed with 1 mCi of [3H]thymidine for 16 hr, and harvestedmice were obtained as described previously (Kawai and Ohashi,
as described.1995).
FTOCs Intracellular Perforin Staining
Timed breedings were established between TCR CD82/2 H-2b males Thymic cell suspensions were initially stained with rat anti-mouse
and CD82/2 H-2b females. At day 16 of gestation, females were PE-conjugated anti-Va2 (B20.1) (PharMingen). These cells were then
sacrificed, and thymic lobes were removed from the fetuses. DNA sorted using a FACStar Plus instrument (Becton Dickinson) to collect
was extracted from embryonic tails so that transgenic fetuses could Va2hi thymocytes. The thymocytes were fixed in 4 ml 70% ethanol
be determined using primers specific for the Va2 TCR transgene (2208C) and incubated on ice for 30 min. Following this incubation
(Sebzda et al., 1996). The fetal thymic lobes were placed on 0.8 mm period, the cells were pelleted and resuspended in 0.5% HIO3. Ten
polycarbonate filters (Costar, Cambridge, MA), which floated on 1 minutes later, the cells were washed and incubated with 1% bovine
ml of Iscove's modified Dulbecco's medium (IMDM), 13 Nutridoma- serum albumin±PBS for 30 min. The cells were then washed and
SP (Boehringer Mannheim, Indianapolis, IN), 5 3 1025 M2-mercapto- stained with rat anti-mouse perforin antibody (PI-8 ascitic fluid
ethanol, penicillin, streptomycin, 2 mM glutamine, and designated 1:500) (kindly provided by Dr. K. Okumura) for 1 hr. The thymocytes
peptides. These lobes were then cultured for 6 days at 378C, during were subsequently washed and stained with FITC-conjugated goat
which time the medium was changed daily. After this incubation anti-rat mAb (Tago, Burlingame, CA) for 1 hr.
period, the thymic lobes were teased apart and stained with mAbs
at 48C in PBS containing 2% fetal calf serum (FCS) and 0.2% NaN3. Acknowledgments
Three-color analysis was done with rat anti-mouse FITC-conjugated
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